logo

For the Inventor, By the Inventor

Schlieren, Switzerland

Cytos Biotechnology Ag

USPTO Granted Patents = 31

% Expired Patents = 67.7



Forward Citations = 438

Loading Chart...
Loading Chart...

47 inventors (with patents filed for the assignee):

goldMedal Martin F Bachmann (24 out of 27 patents)

silverMedal Patrik Maurer (10 out of 11 patents)

bronzeMedal Alain Tissot (9 out of 10 patents)

4.  Wolfgang Andreas Renner (8 out of 13 patents)

5.  Paul Pumpens (4 out of 8 patents)

6.  Indulis Cielens (4 out of 5 patents)

7.  Regina Renhofa (4 out of 5 patents)

8.  Philippe Paul Saudan (3 out of 4 patents)

9.  Katrin Schwarz (3 out of 4 patents)

10.  Edwin Meijerink (3 out of 5 patents)

11.  Karl Proba (3 out of 7 patents)

12.  Gunther Spohn (3 out of 3 patents)

13.  Peter Sebbel (3 out of 3 patents)

14.  Franziska Lechner (3 out of 3 patents)

15.  Frank Hennecke (3 out of 3 patents)


Core Competencies:
Immunostimulatory Substances
Virus-Like Particles
Oligonucleotides
Antigen Arrays
Monoclonal Antibodies
Hapten-Carrier Conjugates
Gene Expression
Protein Purification
Vaccines
Peptide-Carrier Conjugates
Molecular Antigen Arrays
Hypersensitivity Treatment

31 patents:

1. 8691209 - Packaging of immunostimulatory substances into virus-like particles: method of preparation and use (2014-04-08),
2. 8586728 - Oligonucleotides containing high concentrations of guanine monomers (2013-11-19),
3. 8574564 - Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity (2013-11-05),
4. 8541559 - Process for producing aggregated oligonucleotides (2013-09-24),
5. 8449874 - Interleukin-1 muteins linked to virus-like particles to treat IL-1 associated diseases (2013-05-28),
6. 8344111 - Human monoclonal nicotine specific antibodies (2013-01-01),
7. 8187607 - Hapten-carrier conjugates and uses thereof (2012-05-29),
8. 7959928 - VLP-antigen conjugates and their uses as vaccines (2011-06-14),
9. 7959924 - Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof (2011-06-14),
10. 7888098 - Scalable process for protein purification (2011-02-15),
11. 7785873 - Antigen arrays for treatment of bone disease (2010-08-31),
12. 7767212 - CAT allergen conjugates and uses thereof (2010-08-03),
13. 7666408 - Angiotensin peptide-carrier conjugates and uses thereof (2010-02-23),
14. 7572451 - Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof (2009-08-11),
15. 7517520 - Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use (2009-04-14),
Company Overview
Cytos Biotechnology AG is a biopharmaceutical company based in Schlieren, Switzerland, specializing in the development of innovative therapeutic solutions. The organization focuses on harnessing its proprietary technology platforms to create novel treatments for various diseases, particularly in the fields of immunology and oncology. With a commitment to advancing healthcare, Cytos aims to address unmet medical needs through its research and development efforts, contributing to the evolving landscape of biomedicine.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

31 Patents

#3 in Schlieren

#437 in Switzerland

#21,284 in the World

Schlieren, CH
Schlieren, Switzerland

Cytos Biotechnology Ag

Forward Citations = 438

47 inventors:

goldMedal Martin F Bachmann (24 out of 27 patents)

silverMedal Patrik Maurer (10 out of 11 patents)

bronzeMedal Alain Tissot (9 out of 10 patents)

4.  Wolfgang Andreas Renner (8 out of 13 patents)

5.  Paul Pumpens (4 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cytos Biotechnology Ag. Retrieved from https://idiyas.com/company/cytos-biotechnology-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…